Raytheon Technologies’ top boss warned on Oct. 26 that the U.S. aerospace and defense firm will lose ‘several thousand’ employees who refused to take Covid-19 vaccines, as the company prepares to meet the Biden administration’s Dec. 8 deadline for immunization.

As the work force returns to the office, life science companies are having to take their stance on vaccine policy. Some have chosen a strict mandate, others a mandate with options, and others have yet to issue an edict.

The U.S. Securities and Exchange Commission halted registrations of U.S. initial public offerings (IPOs) by Chinese companies. 

The Biden administration plans to donate 500 million Pfizer coronavirus vaccine doses to nearly 100 countries over the next two years, three sources familiar with the matter told Reuters on June 9.

The United States is preparing for the possibility that a booster shot will be needed between nine to 12 months after people are initially vaccinated against Covid-19, a White House official said on April 15.

Moncef Slaoui, who served as chief scientist for the Operation Warp Speed response to the Covid-19 pandemic under former President Donald Trump, was fired as chairman of the board of directors of Galvani Bioelectronics following the “substantiation” of allegations of sexual harassment and inappropriate conduct.

Johnson & Johnson Chief Executive Officer Alex Gorsky told CNBC that people may need to get vaccinated against Covid-19 annually over the next several years, like seasonal flu shots.

Moderna Inc. proposed filling vials with additional doses of the Covid-19 vaccine to ease a crunch in manufacturing as the company approaches the manufacturing of almost a million doses a day.

Moderna Inc. asked the U.S. Food and Drug Administration for permission to fill the company’s Covid-19 vaccine vials with up to five additional doses to ease a crunch in manufacturing, CNBC reported.

Moderna started development on a booster to the company’s Covid-19 vaccine, which is hoped to work against the recently discovered (and more transmissible) SARS-CoV-2 variant from South Africa.